CSE/XBRA (CSE/XBRA)

Canadian Securities Exchange: CSE/XBRA · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	420.7K
Shares out	84.1M
Volume	3,200
Beta	-2.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 420.7K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

S&P 500-0.5%

Nasdaq Composite-4.9%

Dow Jones Industrial Average+2.2%

Russell 2000+1.2%

All CSE/XBRA indicators

Market & fundamental data

Available fields

Groups with data

Currency

CAD

Showing 82 of 82 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Founded	2019
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA98402E2069
Last refreshed	2026-10-29
Last stock split date	2023-02-28
Last stock split type	Reverse
Market cap	CAD 420,724
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	2833
Stock price date	2025-09-04
Symbol	cse/XBRA
Website	https://xebrabrands.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Industry forward P/E	34.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	-6.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.04
1D price change	0%
1M price change	-75%
1M total return	-75%
1Y price change	-90%
1Y return CAGR	-90.02%
1Y total return	-90%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.04
3M price change	-85.71%
3M total return	-85.71%
3Y price change	-98.46%
3Y return CAGR	-75.12%
3Y total return	-98.46%
50-day SMA	CAD 0.02
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.09
52-week high date	2025-03-28
52-week low	CAD 0.01
52-week low date	2025-09-04
6M price change	-88.89%
6M total return	-88.89%
All-time high	CAD 4.15
All-time high date	2021-12-02
All-time low	CAD 0.01
All-time low date	2025-08-19
Average true range (ATR)	CAD 0.00
Average volume	182.7K
Beta (1Y)	0
Beta (2Y)	-0.77
Beta (5Y)	-2.04
Change from 52-week high	-94.44%
Change from 52-week low	0%
Change from all-time high	-99.88%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 16
High price	CAD 0.01
Low price	CAD 0.01
Monthly RSI	43.9
Open price	CAD 0.01
Previous close	CAD 0.01
Price vs 150-day SMA	-87.89%
Price vs 20-day SMA	-59.02%
Price vs 200-day SMA	-88.21%
Price vs 50-day SMA	-78.63%
Relative volume	0.02
RSI	32.88
Sharpe ratio	0.01
Sharpe ratio (3Y)	0.63
Sortino ratio	0.04
Sortino ratio (3Y)	1.57
Volume	3.2K
Weekly RSI	32.56
YTD price change	-80%
YTD total return	-80%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares held by insiders	20.34%
Shares outstanding	84.1M

Deeper analysis on CSE/XBRA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/XBRA report

Is a complete CSE/XBRA research report available?

No complete published report is available for cse/XBRA (CSE/XBRA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/XBRA (CSE/XBRA)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/XBRA

Valuation

Trading

Next earnings

Sector percentile context

All CSE/XBRA indicators

Profile and market data

Valuation

Financial strength

Performance and technicals

Ownership and float

Deeper analysis on CSE/XBRA

Frequently asked questions